Stay updated with breaking news from Nasdaq Nrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Royal Bank of Canada restated their outperform rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Get Rating) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $30.00 target price on the stock. A number of other research firms have also issued reports on NRIX. Stifel Nicolaus lowered their target […]
Royal Bank of Canada restated their outperform rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Get Rating) in a report published on Friday, Benzinga reports. Royal Bank of Canada currently has a $30.00 price target on the stock. A number of other analysts also recently issued reports on the stock. Needham & Company LLC dropped […]
Nurix Therapeutics (NASDAQ:NRIX – Get Rating) is set to announce its earnings results on Thursday, April 13th. Nurix Therapeutics (NASDAQ:NRIX – Get Rating) last released its earnings results on Thursday, February 9th. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Nurix Therapeutics had a negative […]
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month […]
Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients regardless of Bruton’s...